Skip to content
TrialScanner

NCT03290560

Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke

Phase 2CompletedDMACLead

Registry record

Lead sponsor
DiaMedica Therapeutics Inc
Conditions
Acute Ischemic Stroke
Primary completion
Jan 23, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03290560 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.